Brain UK study ref: 16/015,
Lay summary,
Project status: Closed
The development of a molecular methodology for improved detection of Isocitrate Dehydrogenase mutations in diffuse gliomas
Dr Rosalind Ganderton, University Hospital Southampton NHS Foundation Trust
Changes in our DNA are often found in cancer. In the hospital laboratory we can set up tests to look for these changes, to help diagnose and treat cancer. In a brain cancer called glioma, we need to find some better tests to help with getting the diagnosis right. We want to try a new method called ‘digital PCR’ that should help us give a more accurate way of looking for a mutation in the gene IDH1, which is very common in this cancer. We will compare the method with the way the test is done now, looking at cells down a microscope, to see if we can get a better test. We also want to add in some ‘DNA sequencing’ to try and pick up rarer IDH mutations that can be found in glioma; currently our hospital can’t offer this extra service. These extra tests will mean we can help the doctors to make a more accurate diagnosis of the disease. This should in turn make sure the patients get the most appropriate treatment.